Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Chemical Investors Group (ICIG) is a privately owned industrial holding company that specializes in acquiring and operating mid-sized chemical and pharmaceutical businesses. Founded in 2004, the group has built a significant presence in the life sciences sector through its core platforms, including CordenPharma (a leading CDMO, sold to Astorg in 2022), WeylChem (fine chemicals), and Corden BioChem (biotechnology). ICIG focuses on niche markets and specialized manufacturing technologies, such as high-potency APIs, peptides, and fermentation-based production. The group's strategy involves acquiring non-core assets from major pharmaceutical corporations and transforming them into independent, high-value operating companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Chemical.